Abstract
This article has no abstract.
This article has no abstract.
I Issemann and S Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990.
View at: Google ScholarP T Cheng and R Mukherjee, “PPARs as targets for metabolic and cardiovascular diseases,” Mini Reviews in Medicinal Chemistry, vol. 5, no. 8, pp. 741–753, 2005.
View at: Google ScholarA Z Fernandez, “PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome,” Current Opinion in Investigational Drugs, vol. 5, no. 9, pp. 936–940, 2004.
View at: Google ScholarP Delerive, J C Fruchart, and B Staels, “Peroxisome proliferator-activated receptors in inflammation control,” Journal of Endocrinology, vol. 169, no. 3, pp. 453–459, 2001.
View at: Google ScholarS Cuzzocrea, B Pisano, L Dugo et al., “Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-, reduces acute inflammation,” European Journal of Pharmacology, vol. 483, no. 1, pp. 79–93, 2004.
View at: Google ScholarJ J Schlezinger, G J Howard, C H Hurst et al., “Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2,” Journal of Immunology, vol. 173, no. 5, pp. 3165–3177, 2004.
View at: Google ScholarF Zhang, B Lavan, and F M Gregoire, “Peroxisome proliferator-activated receptors as attractive antiobesity targets,” Drug News & Perspectives, vol. 17, no. 10, pp. 661–669, 2004.
View at: Google ScholarD Patsouris, M Muller, and S Kersten, “Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance,” Current Opinion in Investigational Drugs, vol. 5, no. 10, pp. 1045–1050, 2004.
View at: Google ScholarE S Tien, J P Gray, J M Peters, and J P Vanden Heuvel, “Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes,” Cancer Research, vol. 63, no. 18, pp. 5767–5780, 2003.
View at: Google ScholarC M Komar, “Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling,” Reproductive Biology and Endocrinology, vol. 3, p. 41, 2005.
View at: Google ScholarJ C Corton and P J Lapinskas, “Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?” Toxicological Sciences, vol. 83, no. 1, pp. 4–17, 2005.
View at: Google Scholar